在患有急性淋巴细胞白血病的儿科患者中,TBI与非TBI的调节方案之间的全面比较:系统性审查和元分析

Faezeh Ansari1, Maryam Behfar1, Leila Jafari1

  • 1Pediatric Cell and Gene Therapy Research Centre, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Leukemia research
|November 2, 2023
PubMed
概括

非TBI治疗方案在整体生存期方面与小儿ALL患者的TBI一样有效,但TBI导致较高的晚期毒性. 非TBI调节是一种可行的替代方案.